Episode 55: CHAPTER-3 , Pharvaris Oral Prophylaxis Phase 3 Study

HAE Speaks
07/07/2025 12 min

Listen "Episode 55: CHAPTER-3 , Pharvaris Oral Prophylaxis Phase 3 Study"

Descargar episodio Ver en sitio original

Episode Synopsis

In this episode of the HAE Speaks Podcast, Dr. Raffi Tachdjian (UCLA) and Pharvaris discuss the HAE CHAPTER-3 Study — a new HAE attack prevention trial currently enrolling. The study explores the safety and effectiveness of deucrictibant, an investigational once-daily oral treatment aimed at preventing HAE attacks.Thank you to Pharvaris for sponsoring this episode of the HAE Speaks Podcast!

More episodes of the podcast HAE Speaks

Episode 58: 10 Must-Ask Insurance Questions for HAE 09/10/2025
Episode 57: Beyond “Good Enough”: How One Patient Redefined HAE Control 16/09/2025
Episode 56: Understanding Medicare Enrollment 21/08/2025
Episode 54: How to Ease Your Mind 18/06/2025
Episode 53: Legislative Update from our Washington Office 11/06/2025
Episode 52: End of Progression: Understanding the Full Spectrum of a Bradykinin-mediated Angioedema Attack 05/05/2025
Episode 51: Legislative Series - Insights from Two Grassroots Leaders 03/04/2025
Episode 50: Innovations in HAE with KalVista 31/10/2024
Episode 49: Ahead of the Swell: Uncovering the Target That Could Stop Attacks 20/08/2024
Episode 48: Spotlight on HAEA Grassroots Advocacy Network Regional Leaders 05/08/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA